Effects of insulin and clonazepam on DNA damage in diabetic rats submitted to the forced swimming test

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 703, Issue 2, 2010, Pages 187-190

  Wayhs, Carlos Alberto Yasin ^a,b   Manfredini, Vanusa ^a,b   Sitta, Angela ^a,c   Deon, Marion ^a,c   Ribas, Graziela S ^a,b   Vanzin, Camila S ^b   Biancini, Giovana B ^b   Nin, Maurício S ^d   Barros, Helena M T ^d   Vargas, Carmen Regla ^a,b,c  

^a Programa de Pós Graduação em Medicina   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

Clonazepam; Comet assay; Depression; Diabetes; DNA damage; Insulin; Streptozotocin

Indexed keywords

CLONAZEPAM; HUMAN INSULIN; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DRUG EFFECT; FORCED SWIMMING TEST; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

ANIMALS; CLONAZEPAM; COMET ASSAY; DIABETES MELLITUS, EXPERIMENTAL; DNA DAMAGE; DRUG THERAPY, COMBINATION; INSULIN; LEUKOCYTES; RATS; RATS, WISTAR; STRESS, PSYCHOLOGICAL; SWIMMING;

ANIMALIA; RATTUS;

EID: 78549247411     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2010.08.017     Document Type: Article

References (39)

1. Apelqvist J., Bakker K., Van Houtum W.H., Schaper N.C. Practical guidelines on the management and prevention of the diabetic foot: based upon the International Consensus on the Diabetic Foot (2007) Prepared by the International Working Group on the Diabetic Foot. Diabetes Metab. Res. Rev. 2008, 24:116-118.
2. Bellush L.L., Reid S.G., North D. The functional significance of biochemical alterations in streptozotocin-induced diabetes. Physiol. Behav. 1991, 50:973-981.
3. Miles W.R., Root H.F. Psychologic tests applied to diabetic patients. Arch. Int. Med. 1922, 30:767-777.
4. Biessels G.J., Van Der Heide L.P., Kamal A., Bleys R.L., Gispen W.H. Aging and diabetes: implications for brain function. Eur. J. Pharmacol. 2002, 441:1-14.
5. Sima A.A., Kamiya H., Li Z.G. Insulin C-peptide, hyperglycemia, and central nervous system complications in diabetes. Eur. J. Pharmacol. 2004, 490:187-197.
6. Gavard J.A., Lustman P.J., Clouse R.E. Prevalence of depression in adults with diabetes. Diabetes Care 1993, 16:1167-1178.
7. Téllez-Zentero J.F., Cardiel M.H. Risk factors associated with depression in patients with type 2 diabetes mellitus. Arch. Med. Res. 2002, 33:53-60.
8. Lustman P.J., Griffith L.S., Gavard J.A., Clouse R.E. Depression in adults with diabetes. Diabetes Care 1992, 15:1631-1639.
9. Shehatah A., Rabie M.A., Al-Shahry A. Prevalence and correlates of depressive disorders in elderly with type 2 diabetes in primary health care settings. J. Affect. Disord. 2010, 123:197-201.
10. Gomez R., Barros H.M.T. Ethopharmacology of the antidepressant effect of clonazepam in diabetic rats. Pharmacol. Biochem. Behav. 2000, 66:329-335.
11. Hilakivi-Clarke L.A., Wozniak K.M., Durcan M.J., Linnoila M. Behavior of streptozotocin-diabetic mice in tests of exploration, locomotion, anxiety, depression and aggression. Physiol. Behav. 1990, 48:429-433.
12. Haeser A.S., Sitta A., Barschak A.G., Deon M., Barden A.T., Schmitt G.O., Landgraff S., Gomez R., Barros H.M., Vargas C.R. Oxidative stress parameters in diabetic rats submitted to forced swimming test: the clonazepam effect. Brain Res. 2007, 1154:335-338.
13. Guyot L.L., Diaz F.G., O'regan M.H., Song D., Phillis J.W. The effect of streptozotocin-induced diabetes on the release of excitotoxic and other amino acids from the ischemic rat cerebral cortex. Neurosurgery 2001, 48:385-391.
14. Duarte A.I., Santos M.S., Seica R., Oliveira C.R. Oxidative stress affects synaptosomal gamma-aminobutyric acid and glutamate transport in diabetic rats: the role of insuline. Diabetes 2004, 53:2110-2116.
15. Rajtar G., Zolkowska D., Keinrok Z. Effect of diazepam and clonazepam on the function of isolated rat platelet and neutrophils. Intern. Med. J. Exp. Clin. Res. 2002, 8:37-44.
16. Imaeda V., Aoki T., Kondo Y., Hori M., Ogata M., Obayashi H., Hasegawa G., Nakamura N., Tokuda K., Nishino H., Yoshikawa T., Kondo M. Protective effects of fluvastatin against reactive oxygen species induced DNA damage and mutagenesis. Free Radic. Res. 2001, 34:33-44.
17. Bonnefont-Rousselot D., Beaudeux J.L., Therond P., Peynet J., Legrand A., Delattre J. Diabetes mellitus, oxidative stress and advanced glycation endproducts. Ann. Pharm. Fr. 2004, 62:147-157.
18. Halliwell B., Gutteridge J.M.C. Free Radicals in Biology and Medicine 2007, Oxford University Press, New York. 3rd ed.
19. Porsolt R.D., Le Pichon M., Jalfre M. Depression: a new model sensitive to antidepressant treatment. Nature 1977, 266:730-732.
20. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantification of low levels of DNA damage in individual cells. Exp. Cell. Res. 1988, 175:184-191.
21. Tice R.R., Agurell D., Anderson D., Burlinson B., Hartmann A., Kobayashi H., Miyamae Y., Rojas E., Ryu J.C., Sasaki Y.F. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutagen. 2000, 35:206-221.
22. Hartmann A., Agurell E., Beevers C., Brendler-Schwaab S., Burlinson B., Clay P., Collins A., Smith A., Speit G., Thybaud V., Tice R.R. Recommendations for conducting the in vivo alkaline comet assay. Mutagenesis 2003, 18:45-51.
23. Nadin S., Vargas-Roig L., Ciocca D. A silver staining method for single-cell gel assay. J. Histochem. Cytochem. 2001, 49:1183-1186.
24. Wiernsperger N.F. Oxidative stress as a therapeutic target in diabetes: revisiting the controversy. Diabetes Metab. 2003, 29:579-585.
25. Stetina R., Varvarovska J., Rusavy Z., Pomahacova R., Racek J., Lacigov S., Trefil L., Siala K., Stozicky F. Oxidative stress DNA damage and DNA repair capacity in children with type 1 diabetes mellitus. Toxicol. Lett. 2006, 164:S134.
26. Wu H., Guo H., Zhao R. Effect of Lycium barbarum polysaccharide on the improvement of antioxidant ability and DNA damage in NIDDM rats. Yakugaku Zasshi 2006, 126:365-371.
27. Fidan A., Dündar Y. The effects of Yucca schidigera and Quillaja saponaria on DNA damage, protein oxidation, lipid peroxidation, and some biochemical parameters in streptozotocin-induced diabetic rats. J. Diabetes Complications 2008, 22:348-356.
28. Balkis B.S., Fadilah R.N., Ezlan A., Khairul O., Mokhtar A.B., Jamaludin M. Oxidative stress and DNA damage in streptozotocin-induced diabetic rats: effects of alpha lipoic acid. J. Biol. Sci. 2008, 8:622-627.
29. Saydah S.H., Platz E.A., Rifai N., Pollak M.N., Brancati F.L., Helzlsouer K.J. Association of markers of insulin and glucose control with subsequent colorectal cancer risk. Cancer Epidemiol. Biomarkers Prev. 2003, 12:412-418.
30. Anderson D., Yu T.W., Wright J., Ioannides C. An examination of DNA strand breakage in the comet assay and antioxidant capacity in diabetic patients. Mutat. Res. 1998, 398:151-161.
31. Dandona P., Thuru K., Cook S., Snyder B., Makowski J., Armstrong D., Nicotera T. Oxidative damage to DNA in diabetes mellitus. Lancet 1996, 347:444-445.
32. Dinçer Y., Akçay T., İlkova H., Alademir Z., Ozbay G. DNA damage and antioxidant defense in peripheral leukocytes of patients with Type I diabetes mellitus. Mutat. Res. 2003, 527:49-55.
33. Leonard E.E. Effects of depression on work loss and disability bed days in individuals with diabetes. Diabetes Care 2004, 27:1751-1753.
34. Imaeda A., Kaneko T., Aoki T., Kondo Y., Nagase H. DNA damage and the effect of antioxidants in streptozotocin-treated mice. Food Chem. Toxicol. 2002, 40:979-987.
35. Kocic R., Pavlovic D., Kocic G. Impact of intensive insulin treatment on the development and consequences of oxidative stress in insulin-dependent diabetes mellitus. Vojnosanit Pregled. 2007, 64:623-628.
36. Monnier L., Colette C., Mas E., Michel F., Cristol J.P., Boegner C., Owens D.R. Regulation of oxidative stress by glycaemic control: evidence for an independent inhibitory effect of insulin therapy. Diabetologia 2010, 53:562-571.
37. Chevassus H., Mourand I., Molinier N., Lacarelle B., Brun J.F., Petit P. Assessment of single-dose benzodiazepines on insulin secretion, insulin sensitivity and glucose effectiveness in healthy volunteers: a double-bind, placebo-controlled, randomized cross-over trial. BMC Clin. Pharmacol. 2004, 4:4: 3.
38. Pearce D.A., Atkinson M., Tagle D.A. Glutamic acid decarboxylase autoimmunity in Batten disease and other disorders. Neurology 2004, 63:2001-2005.
39. Yoshimoto T., Doi M., Fukai N., Izumiyama H., Wago T., Minami I., Uchimura I., Hirata Y. Type 1 diabetes mellitus and drug-resistant epilepsy: presence of high titer of anti-glutamic acid decarboxylase autoantibodies in serum and cerebrospinal fluid. Intern. Med. 2005, 44:1174-1177.